Position / Title
Executive Director
Institution
Biologics and Biosimilars Collective Intelligence Consortium
Online Profile
Cate Lockhart, PharmD, PhD, serves as the Executive Director of the BBCIC who provides post-market surveillance of biosimilars biosimilars: What is a Biosimilar? A biosimilar is a type of biologic medication. The term “biosimilar” means that the medication is highly similar to the already approved brand name biologic (“originator” medication). Biosimilars are not generic versions of the original biologic. Difference Between… and their corresponding novel biologics.
Physician Status